Y-box protein 1 stimulates mesangial cell proliferation via activation of ERK1/2

Nephron - Experimental Nephrology

Volumn 113, Issue 1, 2009, Pages

  Feng, Quancheng ^a   Huang, Songming ^a   Zhang, Aihua ^a   Chen, Qiuxia ^a   Guo, Xirong ^a   Chen, Ronghua ^a   Yang, Tianxin ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell cycle; Cell proliferation; Extracellular signal regulated kinase 1 2; Mesangial cells; Y box protein 1

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CYCLIN A2; CYCLIN D1; CYCLIN E; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PROTEIN P21; PROTEIN P27; THYMIDINE; Y BOX BINDING PROTEIN 1;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IMMUNOBLOTTING; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSIENT TRANSFECTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CELL LINE; CELL PROLIFERATION; CYCLIN D1; CYCLIN E; MESANGIAL CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION; Y-BOX-BINDING PROTEIN 1;

EID: 67649836789     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228079     Document Type: Article

References (39)

1. Johnson RJ: The glomerular response to injury: progression or resolution? Kidney Int 1994;45:1769-1782.
2. Abboud HE: Growth factors in glomerulonephritis. Kidney Int 1993;43:252-267.
3. Floege J, Eng E, Young BA, Johnson RJ: Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int 1993;39(suppl):S47-S54.
4. Johnson RJ, Floege J, Couser WG, Alpers CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 1993;4:119-128.
5. Hunter T, Pines J: Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell 1994;79:573-582.
6. Sherr CJ: Mammalian G1 cyclins. Cell 1993;73:1059-1065.
7. Hunter T: Braking the cycle. Cell 1993;75:839-841.
8. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995;81:323-330.
9. Bokemeyer D, Panek D, Kitahara M, Trzaskos JM, Muller CE, Hockemeyer J, Kunter U, Boor P, Floege J, Kramer HJ, Ostendorf T: The MAP kinase ERK regulates renal activity of cyclin-dependent kinase 2 in experimental glomerulonephritis. Nephrol Dial Transplant 2007;22:3431-3441.
10. Bokemeyer D, Guglielmi KE, McGinty A, Sorokin A, Lianos EA, Dunn MJ: Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J Clin Invest 1997;100:582-588. (Pubitemid 27340505)
11. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153-183. (Pubitemid 32458157)
12. Yoon S, Seger R: The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 2006;24:21-44. (Pubitemid 43108774)
13. Didier DK, Schiffenbauer J, Woulfe SL, Zacheis M, Schwartz BD: Characterization of the CDNA encoding a protein binding to the major histocompatibility complex class II Y-box. Proc Natl Acad Sci USA 1988;85:7322-7326. (Pubitemid 18241876)
14. Swamynathan SK, Nambiar A, Guntaka RV: Role of single-stranded DNA regions and Y-box proteins in transcriptional regulation of viral and cellular genes. FASEB J 1998;12:515-522. (Pubitemid 28183510)
15. Ladomery M, Sommerville J: A role for Y-box proteins in cell proliferation. Bioessays 1995;17:9-11.
16. Kohno K, Uchiumi T, Niina I, Wakasugi T, Igarashi T, Momii Y, Yoshida T, Matsuo K, Miyamoto N, Izumi H: Transcription factors and drug resistance. Eur J Cancer 2005;41:2577-2586.
17. Van Roeyen CR, Eitner F, Martinkus S, Thieltges SR, Ostendorf T, Bokemeyer D, Luscher B, Luscher-Firzlaff JM, Floege J, Mertens PR: Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease. J Am Soc Nephrol 2005;16:2985-2996. (Pubitemid 44743496)
18. Zhang A, Ding G, Huang S, Wu Y, Pan X, Guan X, Chen R, Yang T: C-jun NH 2 -terminal kinase mediation of angiotensin ii-induced proliferation of human mesangial cells. Am J Physiol Renal Physiol 2005;288:F1118-F1124. (Pubitemid 40677081)
19. Zhang A, Jia Z, Guo X, Yang T: Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am J Physiol Renal Physiol 2007;293:F723-F731. (Pubitemid 47403342)
20. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-1163.
21. Elledge SJ: Cell cycle checkpoints: preventing an identity crisis. Science 1996;274:1664-1672.
22. Kyriakis JM, Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807-869.
23. Bokemeyer D, Sorokin A, Dunn MJ: Multiple intracellular MAP kinase signaling cascades. Kidney Int 1996;49:1187-1198. (Pubitemid 26166398)
24. Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM: Stress-activated protein kinases in cardiovascular disease. Circ Res 1996;78:947-953. (Pubitemid 26166702)
25. Shibao K, Takano H, Nakayama Y, Okazaki K, Nagata N, Izumi H, Uchiumi T, Kuwano M, Kohno K, Itoh H: Enhanced coexpression of YB-1 and DNA topoisomerase II α genes in human colorectal carcinomas. Int J Cancer 1999;83:732-737.
26. Shankland SJ: Cell-cycle control and renal disease. Kidney Int 1997;52:294-308.
27. Terada Y, Yamada T, Nakashima O, Tamamori M, Ito H, Sasaki S, Marumo F: Overexpression of cell cycle inhibitors (p16INK4 and p21Cip1) and cyclin D1 using adenovirus vectors regulates proliferation of rat mesangial cells. J Am Soc Nephrol 1997;8:51-60. (Pubitemid 27496515)
28. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ: Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 1996;50:1230-1239. (Pubitemid 26342814)
29. Qiu LQ, Sinniah R, Hsu SI: Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy. Lab Invest 2004;84:1112-1125. (Pubitemid 39128257)
30. Wolf G, Reinking R, Zahner G, Stahl RA, Shankland SJ: Erk-1/2 phosphorylates p27(kip1): functional evidence for a role in high glucose-induced hypertrophy of mesangial cells. Diabetologia 2003;46:1090-1099. (Pubitemid 37041239)
31. Shankland SJ, Wolf G: Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 2000;278:F515-F529.
32. Ophascharoensuk V, Fero ML, Hughes J, Roberts JM, Shankland SJ: The cyclin-dependent kinase inhibitor p27kip1 safeguards against inflammatory injury. Nat Med 1998;4:575-580. (Pubitemid 28237356)
33. Hiromura K, Pippin JW, Fero ML, Roberts JM, Shankland SJ: Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). J Clin Invest 1999;103:597-604. (Pubitemid 29122412)
34. Capowski EE, Esnault S, Bhattacharya S, Malter JS: Y-box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J Immunol 2001;167:5970-5976. (Pubitemid 33062794)
35. Chen CY, Gherzi R, Andersen JS, Gaietta G, Jurchott K, Royer HD, Mann M, Karin M: Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 2000;14:1236-1248. (Pubitemid 30327504)
36. Evdokimova V, Ruzanov P, Imataka H, Raught B, Svitkin Y, Ovchinnikov LP, Sonenberg N: The major mRNA-associated protein YB-1 is a potent 5′ cap-dependent mRNA stabilizer. EMBO J 2001;20:5491-5502. (Pubitemid 32959469)
37. Evdokimova V, Ruzanov P, Anglesio MS, Sorokin AV, Ovchinnikov LP, Buckley J, Triche TJ, Sonenberg N, Sorensen PH: Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species. Mol Cell Biol 2006;26:277-292.
38. Coles LS, Lambrusco L, Burrows J, Hunter J, Diamond P, Bert AG, Vadas MA, Goodall GJ: Phosphorylation of cold shock domain/Ybox proteins by ERK2 and GSK3β and repression of the human VEGF promoter. FEBS Lett 2005;579:5372-5378. (Pubitemid 41395158)
39. Skabkina OV, Lyabin DN, Skabkin MA, Ovchinnikov LP: YB-1 autoregulates translation of its own mRNA at or prior to the step of 40S ribosomal subunit joining. Mol Cell Biol 2005;25:3317-3323.